spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Drug-Eluting Coronary Stent 

 HSMN NewsFeed - 13 May 2022
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 13 Jul 2020
SINOMED(R) Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme(R) Coronary Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Jan 2018
Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 15 Dec 2015
Svelte Medical Systems Announces CE Mark Certification of SLENDER IDS(TM)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 Sep 2014
World’s First Integrated Delivery System Meets All Endpoints in the Direct II Randomized, Controlled Drug-Eluting Coronary Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Nov 2013
Svelte Medical Systems Announces Enrollment Complete in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2013
Svelte Drug-Eluting Stent Utilizing New Class of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months in First-In-Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Aug 2012
Cardionovum(R) Expects to Launch Next-Generation Product: Drug-Eluting Coronary Stent System, “PROLIMUS Biograde”
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Feb 2012
Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 4 Nov 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jun 2011
Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent(R) Drug-Eluting Coronary Stent Based on Early Clinical Data
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Feb 2011
REVA Expands Management Team With Key Executive Hire
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 24 Jan 2011
Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Sep 2010
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 3 Aug 2010
Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 8 Dec 2009
Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business
Devices Cardiology Personnel
 HSMN NewsFeed - 22 Sep 2009
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2009
Medtronic Receives Regulatory Approval For Endeavor Drug-Eluting Coronary Stent in Japan
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 4 Nov 2008
SurModics Acquires Drug Delivery Assets of PR Pharmaceuticals
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 30 Oct 2008
SurModics Licenses Hydrophilic Coating for Elixir's Drug-Eluting and Bare Metal Stent Delivery Systems
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 14 Oct 2008
Endeavor(R) Vs. Taxus(R): Medtronic's Drug-Eluting Coronary Stent Linked to Fewer Heart Attacks at Two Years Post Implant
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Sep 2008
Merck & Co., Inc. Discontinues License and Research Collaboration Agreement with SurModics
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 15 Sep 2008
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Sep 2008
Cook Medical Completes Enrollment in First International Trial of First-of-Its-Kind Drug-Eluting Peripheral Stent
Devices Interventional
 HSMN NewsFeed - 16 Jun 2008
Cook Medical Enters Coronary Stent Market in Europe with New CoCr Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 29 May 2008
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 31 Mar 2008
SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2008
Medtronic's New Endeavor(R) Zotarolimus-Eluting Stent Approved for Patients with Coronary Artery Disease in Canada
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 2 Feb 2008
Novation First Group Purchasing Organization (GPO) to Have a National Agreement With Medtronic for the Endeavor(R) Zotarolimus-Eluting Coronary Stent
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 29 Jan 2008
SurModics Announces New Board Directors
Devices Drug Delivery Personnel
 HSMN NewsFeed - 28 Jan 2008
SurModics Expands License Agreement with Merck & Co., Inc.
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 18 Jan 2008
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 31 Oct 2007
SurModics and OakRiver Technology Collaborate on Advanced Coating Equipment
Devices
 HSMN NewsFeed - 24 Oct 2007
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Medtronic Receives CE Mark for Endeavor(R) Resolute Drug-Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 13 Aug 2007
SurModics Acquires BioFX Laboratories
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 1 Aug 2007
SurModics Acquires Brookwood Pharmaceuticals
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 24 May 2007
Boston Scientific Receives CE Mark for TAXUS(R) Liberte(TM) Long Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 May 2007
SPIRIT Clinical Data Reaffirm Strength of TAXUS(R) and PROMUS(TM) Drug-Eluting Coronary Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Medtronic Announces Positive Nine-Month Results for Endeavor(R) Resolute Next Generation Drug-Eluting Stent at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2007
Medtronic Announces Start of 8,800-Patient Clinical Trial Evaluating Drug-Eluting Stent Safety
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2007
Medtronic Announces Schedule of Activities at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stent's Positive Clinical Profile
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2007
Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jan 2007
Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in Europe
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2007
French Court Rules in Favor of evYsio Medical Devices in Patent Litigation Against Abbott Laboratories
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 5 Dec 2006
American Heart Association Statement on Use of Drug-Eluting Coronary Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Nov 2006
SurModics Provides Additional Information on its License Agreement with Conor Medsystems
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 16 Nov 2006
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Abbott Reports Initial Results From World's First Clinical Trial Featuring a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Data Presented by Independent Physician Panel Confirms Low Rate of Thrombosis with Medtronic Endeavor Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Oct 2006
Medtronic Announces Key Activities at Transcatheter Cardiovascular Therapeutics (TCT) Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Oct 2006
Medtronic Announces Largest Clinical Study Evaluating Drug-Eluting Stent Safety
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2006
Abbott to Present New Data Across Its Vascular Portfolio at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Oct 2006
Medtronic Announces Regulatory Approval for the Endeavor Drug-Eluting Coronary Stent System in Australia
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 3 Oct 2006
Abbott Begins Early International Launch of XIENCE(TM) V Everolimus Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Sep 2006
Abbott Announces Continued Expansion of Vascular Operations in Ireland to Prepare for Drug Eluting Stent Manufacturing
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Jul 2006
Resverlogix Corp. Announces License Agreement with Medtronic
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 11 Jul 2006
SurModics' Hydrophilic Coating Used on CYPHER SELECT(TM) PLUS
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Jun 2006
SurModics and AbbeyMoor Medical to Jointly Develop Drug-Device Convergence Products to Treat Diseases of the Prostate
Devices Urology
 HSMN NewsFeed - 27 Jun 2006
Medtronic Announces Completion of Patient Enrollment in ENDEAVOR IV Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2006
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2006
Endeavor Registry Data Confirms High Deliverability Success and Broad, Everyday Use by Physicians
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Impressive Clinical Results Show Medtronic ENDEAVOR(TM) Drug-Eluting Coronary Stent Provides Significant Long-Term Safety and Efficacy Benefits
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2006
Patient Registry to Evaluate Long-Term Safety and Efficacy of Cordis Next Generation Drug-Eluting Coronary Stents in Clinical Practice
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2006
SurModics Provides Hydrophilic Coating on Xtent's Drug-Eluting Stent Delivery System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2006
Abbott Announces First Patients Enrolled in ZOMAXX(TM) EUROPE Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2006
Medtronic Announces Schedule of Activities At EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2006
SurModics Licenses Ophthalmic Technology to Bausch & Lomb
Biopharmaceuticals Ophthalmology Licensing
Return to NewsFeed  

 Additional items found! 55

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 55 additional stories matching:
Drug-Eluting Coronary Stent
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!